ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -98.7% | 5,466 | -97.6% | 0.00% | – |
| Q2 2023 | $559 | +432.4% | 230,153 | +1155.1% | 0.00% | – |
| Q1 2023 | $105 | -88.1% | 18,338 | -81.4% | 0.00% | – |
| Q4 2022 | $882 | -99.9% | 98,663 | +19.7% | 0.00% | -100.0% |
| Q3 2022 | $1,172,000 | +5481.0% | 82,407 | +5703.3% | 0.00% | – |
| Q2 2022 | $21,000 | -75.0% | 1,420 | -66.1% | 0.00% | – |
| Q1 2022 | $84,000 | – | 4,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |